No Data
No Data
Hong Kong stock abnormal | zai lab (09688) rose more than 4%, tumor electric field treatment of pancreatic cancer ushered in a breakthrough, positive main results of phase 3 PANOVA-3 study.
zai lab (09688) rose more than 4%, as of the time of publication, it rose by 4.67%, to 23.55 Hong Kong dollars, with a turnover of 16.0669 million Hong Kong dollars.
NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
Sector Update: Health Care Stocks Mixed Pre-Bell Monday
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Monday Ahead of Week Promising Crucial Economic Data
Zai Lab, NovoCure Say Pancreatic Cancer Trial Meets Primary Endpoint
Express News | Zai Lab and Novocure Announce Positive Topline Results From Phase 3 Panova-3 Clinical Trial of Tumor Treating Fields (Ttfields) Therapy for Pancreatic Cancer
No Data
No Data